Home > Insider Trading > Filing (0001593968-21-000706)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313403	Dominick Colangelo	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-03-01	1,548	$48.47	217,647	No	4	S	Direct
Common Stock	Disposition	2021-03-01	2,260	$48.78	215,387	No	4	S	Direct
Common Stock	Acquisiton	2021-03-01	5,625	$2.65	221,012	No	4	M	Direct
Common Stock	Acquisiton	2021-03-01	6,805	$7.20	227,817	No	4	M	Direct
Common Stock	Acquisiton	2021-03-01	15,925	$2.75	243,742	No	4	M	Direct
Common Stock	Disposition	2021-03-01	27,500	$48.06	216,242	No	4	S	Direct
Common Stock	Disposition	2021-03-01	8,692	$48.01	207,550	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-03-01	5,625	$0.00	5,625	$2.65
Common Stock	Stock Option (right to buy)	Disposition	2021-03-01	6,805	$0.00	6,805	$7.20
Common Stock	Stock Option (right to buy)	Disposition	2021-03-01	15,925	$0.00	15,925	$2.75

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,125	2027-05-22	No	4	M	Direct
293,195	2028-02-07	No	4	M	Direct
49,700	2027-02-08	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company.
These options, representing the right to purchase a total of 300,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted.
These options, representing the right to purchase a total of 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.